Holen Sie sich die Stockscreener-App
85.74
0.02%
-0.03
Schlusskurs vom Vortag:
$85.77
Offen:
$85.83
24-Stunden-Volumen:
32,549
Relative Volume:
0.03
Marktkapitalisierung:
$14.89B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
39.69
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
+8.52%
1M Leistung:
+7.05%
6M Leistung:
+15.59%
1J Leistung:
+24.35%
1-Tages-Spanne:
$85.58
$86.36
1-Wochen-Bereich:
$78.18
$86.36
52-Wochen-Spanne:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
85.84 | 14.88B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
586.11 | 207.41B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
204.13 | 58.46B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.89 | 39.60B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.31 | 36.63B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.66 | 32.47B | 27.43B | 1.27B | 1.01B | 1.5829 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Will Solventum Corporation stock gain from strong economy2025 Fundamental Recap & Weekly Sector Rotation Insights - ulpravda.ru
Why Solventum Corporation (KB7) stock signals breakout potential2025 Macro Impact & Fast Moving Trade Plans - ulpravda.ru
Market Moves: Can Solventum Corporation stock retain market dominanceJuly 2025 Catalysts & Safe Entry Zone Tips - ulpravda.ru
Is Solventum Corporation (KB7) stock considered safe haven2025 Price Targets & Fast Entry Momentum Trade Alerts - ulpravda.ru
Assessing Solventum: Insights From 4 Financial Analysts - Benzinga
SOLV Stock: Stifel Raises Price Target to $105, Maintains Buy Ra - GuruFocus
Solventum stock price target raised to $105 from $88 at Stifel - Investing.com Nigeria
Is Solventum stock outperforming the Nasdaq? - MSN
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
AI @ HLTH: Inside Solventum’s AI Healthcare Strategy - HLTH
Solventum Advances Orthodontic Treatment by Helping Shape Modern Orthodontics - Digital Journal
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - Business Wire
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Key sale, acquisition helped 3M spinoff, Solventum, turn around in 2025 - Star Tribune
Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year? - Yahoo Finance
Harbor Capital Advisors Inc. Has $1.31 Million Stake in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Given Consensus Rating of "Hold" by Analysts - MarketBeat
SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio - sharewise.com
Strong Tower Advisory Services Buys 16,851 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Completes Acquisition of Acera Surgical - The Malaysian Reserve
Solventum completes acquisition of Acera Surgical for $725 million By Investing.com - Investing.com Nigeria
Solventum Closes Acquisition of Acera Surgical - marketscreener.com
Solventum completes Acera Surgical acquisition - MassDevice
Solventum completes acquisition of Acera Surgical for $725 million - Investing.com India
Solventum is the top performing healthcare supplies stock YTD - MSN
Solventum is the top performing healthcare supplies stock YTD (SOLV:NYSE) - Seeking Alpha
How Investors Are Reacting To Solventum (SOLV) Expert Guidance Expanding Use Of Prevena ciNPT Dressings - simplywall.st
Wedge Capital Management L L P NC Sells 64,461 Shares of Solventum Corporation $SOLV - MarketBeat
Will Expert Backing for ciNPT Prevena Dressings Redefine Solventum's (SOLV) Advanced Wound Care Edge? - Yahoo Finance
Why retail investors pile into Solventum Corporation stock2025 Top Decliners & Stepwise Swing Trade Plans - Улправда
Is Solventum Stock Underperforming the S&P 500? - MSN
Solventum (SOLV): Assessing Valuation After New Clinical Guidance Expands Prevena Therapy’s Surgical Use - simplywall.st
Argus Research Adjusts Solventum Price Target to $100 From $90, Maintains Buy Rating - marketscreener.com
Assenagon Asset Management S.A. Boosts Position in Solventum Corporation $SOLV - MarketBeat
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy - Finviz
New surgery guidelines expand use of vacuum dressings to protect incisions - Stock Titan
Piper Sandler names Solventum stock its 2026 top idea, maintains $98 target - Investing.com Nigeria
Solventum Corporation reflects on transformative year - MSN
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength - Finviz
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):